pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

Synaffix is a Netherlands-based biotech exclusively focused on continued advancement of a best-in-class ADC technology that results in safer and more effective ADCs, compared to marketed and emerging approaches.

LOCATION

  • Oss, , Netherlands

    • THERAPEUTIC AREAS

  • Oncology

    • WEBSITE

    https://www.synaffix.com/

    CAREER WEBSITE

    None

    SOCIAL MEDIA

    INVESTORS

    aravis-sa biogeneration-ventures bom-capitall m-ventures

    PRESS RELEASES


    Sep 6, 2022

    Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal


    Jan 4, 2022

    Genmab and Synaffix Enter into License Agreement for ADC Technology


    Aug 4, 2021

    Kyowa Kirin Taps Synaffix ADC Technology to Expand Its Pipeline


    Jul 22, 2021

    Synaffix Announces Deal with ProfoundBio Worth up to $246 Million Providing Access to Multiple Novel Linker-Payload Technologies


    Jun 29, 2021

    Synaffix Licenses its Award-Winning ADC Technology in Deal Adding a New ADC to Innovent’s Pipeline


    For More Press Releases
    Google Analytics Alternative